QUEENS CRESCENT PRACTICE
76 QUEENS CRESCENT, LONDON
HF 4
The percentage of patients with a current diagnosis of heart failure due to LVD who are currently treated with an ACE inhibitor or Angiotensin Receptor Blocker, who are additionally treated with a beta-blocker licensed for heart failure, or recorded as intolerant to or having a contraindication to beta-blockers.
| Indicator | Year | Numerator | Denominator | Ratio | Centile |
|---|---|---|---|---|---|
| HF 4 | 2010 | 1 | 1 | 100.0% | |
| HF 4 | 2011 | 2 | 2 | 100.0% | |
| HF 4 | 2012 | 2 | 3 | 66.7% | |
| HF 4 | 2013 | 2 | 2 | 100.0% | |
| HF004 | 2014 | 4 | 4 | 100.0% | |
| HF004 | 2015 | 14 | 14 | 100.0% | |
| HF004 | 2016 | 13 | 13 | 100.0% | |
| HF004 | 2017 | 11 | 11 | 100.0% | |
| HF004 | 2018 | 25 | 28 | 89.3% | |
| HF004 | 2019 | 22 | 23 | 95.7% | |
| HF004 | 2020 | 19 | 19 | 100.0% | |
| HF006 | 2021 | 40 | 46 | 87.0% | |
| HF006 | 2022 | 36 | 38 | 94.7% | |
| HF006 | 2023 | 30 | 31 | 96.8% |
